Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making ...

Aims to enhance Frontage's global lab service capabilities and strengthen its presence in China and the Asia-Pac region.

XyloCor Therapeutics Inc. has appointed John Tucker as President and Chief Executive Officer (CEO), effective immediately.

SmartSkin Technologies has introduced SmartSkin Seal Assurance, a solution designed to give pharmaceutical manufacturers real ...

Invivyd, which focuses on protection against viral infectious diseases, is naming Michael Mina, MD, PhD, chief medical ...

Novartis has unveiled plans to establish a new 46,000-square-foot radioligand therapy (RLT) manufacturing site in Denton, ...

Arcutis Biotherapeutics is promoting Mas Matsuda, senior vice president and general counsel, to executive VP and chief legal ...

Therna Biosciences has joined forces with Charles River to advance single-patient RNA medicines for individuals with severe, ...

Upperton has submitted an application to the UK’s Medicines and Healthcare Products Regulatory Agency for approval of its new ...

Codexis has agreed to manufacture 50 grams of siRNA using its proprietary ECO Synthesis manufacturing platform to support ...

Rovadicitinib is approved in China for myelofibrosis and is in late-stage development for chronic graft-versus-host disease.

Fujifilm Biotechnologies is unveiling a precision purification tool, ShunzymeX, that simplifies downstream processing for ...